Opko Health (OPK) Current Deferred Revenue (2014 - 2024)
Opko Health (OPK) posted Current Deferred Revenue of $6000.0 for Q4 2024, down 14.29% quarter-over-quarter from $7000.0 in Q4 2023, and down 14.29% year-on-year from $7000.0 in Q1 2024.
Opko Health (OPK) Current Deferred Revenue (2014 - 2024) Analysis & Trends
Opko Health (OPK) has reported Current Deferred Revenue for 4 consecutive years, with $6000.0 the latest figure, recorded in Q4 2024.
- Current Deferred Revenue for Q4 2024 came in at $6000.0, down 14.29% year-over-year; the trailing twelve-month figure through Dec 2024 was $6000.0 (down 14.29% YoY), and the FY2024 annual result was $6000.0, down 14.29% from the prior year.
- Current Deferred Revenue was $6000.0 for Q4 2024 at Opko Health, down from $7000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $7000.0 in Q4 2023 and troughed at $6000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Opko Health | 1.16 Bn | 819.20 Mn | 45.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2015 | 254.10 Mn |
| Dec 31, 2014 | 6.70 Mn |